Patent · US Active

Formulations of fluorinated stilbene suitable for PET imaging

US9308284B2 · kind B2 · utility

0Cited by

3References

4Claims

0Family size

Assignee

PIRAMAL IMAGING SA · CH

Inventors

Carsten Olbrich · Berlin, DE
Michael Krause · Berlin, DE
Andreas Burkhard · Basel, CH
Annett Richter · Berlin, DE
Rainer Braun · Magstadt, DE

Key dates

Filing date	Jun 21, 2012
Grant date	Apr 12, 2016
Priority date	—
Expiry date	Jul 14, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K51/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is directed to formulations of lipophilic Amyloid beta ligand stilbene and more particularly to formulations which are capable to be administered parenterally e.g. intravenously, wherein the lipophilic Amyloid beta ligand stilbene is a fluorinated stilbene. Further, the invention is directed to a method for sterile filtration of formulations suitable for PET imaging of mammals pursuant to the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.